Philip P Boudreau
Disclosed holdings of Philip P Boudreau as of 2026-09-01: 82K shares of Abbott Laboratories (ABT), worth about $8.74M at the last close. In 12 months: bought…
What Philip P Boudreau reported holding
As of the latest filing on , Philip P Boudreau reported holding 82,260 shares of Abbott Laboratories (ABT), worth about $8.74M at the last close of $106 (Oct 30, 2026): 70,784 held directly and 11,476 through a spouse, a profit sharing trust. In the last 12 months, Philip P Boudreau bought $201K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Abbott Laboratories ABT | 82,260 | 71K direct · 2,200 spouse · 9,276 profit sharing trust | $106 | $8.74M | Sep 1, 2026 |
Is this Philip P Boudreau’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2020
Philip P Boudreau bought shares on the open market in 2026. Sales in 4 of the 7 years since 2020.
Philip P Boudreau reported 1 open-market purchase and 4 sales since 2020; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 1×1 trade | — |
| 2025 | — | 1×1 trade |
| 2023 | — | 1×1 trade |
| 2021 | — | 1×1 trade |
| 2020 | — | 1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The company behind these filings
- Abbott Laboratories ABT
Philip P Boudreau reported 1 open-market purchase and 4 sales here, 2020 to 2026.
- Market value
- $184B
- Last close
- $106.20
- 12 months
- −14.8%
- Against the S&P 500
- −26.0 pts
- Net margin
- 14.7%
- Revenue (last year)
- $44.3B
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Philip P Boudreau's trades
Has Philip P Boudreau bought shares on the open market?
Philip P Boudreau bought shares on the open market in 2026. Sales in 4 of the 7 years since 2020.
When did Philip P Boudreau last buy or sell shares?
In SEC filings since 2020: the latest open-market purchase is from 2026; the latest open-market sale is from 2025.
Which companies has Philip P Boudreau traded as an insider?
Abbott Laboratories (ABT), from 2020 to 2026: 1 purchase and 4 sales.